about
Cancer classification in the genomic era: five contemporary problemsIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerUnderstanding breast cancer stem cell heterogeneity: time to move on to a new research paradigmHuman correlates of provocative questions in pancreatic pathologyMesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-βThe calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells.Breast cancer molecular subtypes: from TNBC to QNBCInsights into the key roles of proteoglycans in breast cancer biology and translational medicinePrognostic significance of c-Met in breast cancer: a meta-analysis of 6010 casesExamining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based ModelSystems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.Wavelength-modulated differential photoacoustic radar imager (WM-DPARI): accurate monitoring of absolute hemoglobin oxygen saturation.Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell linesWnt signaling in triple negative breast cancer is associated with metastasisAn epigenetically distinct breast cancer cell subpopulation promotes collective invasionPathway-based personalized analysis of breast cancer expression data.Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinomaBiocompatible tissue scaffold compliance promotes salivary gland morphogenesis and differentiationNumber of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma.Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions.Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro.Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers.The Terminal End Bud: the Little Engine that Could.Number of polyploid giant cancer cells and expression of EZH2 are associated with VM formation and tumor grade in human ovarian tumor.Deformable registration for quantifying longitudinal tumor changes during neoadjuvant chemotherapyHypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.The mammary cellular hierarchy and breast cancer.Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrenceComprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study
P2860
Q26781783-5289FD96-E9B8-4045-BACD-BB1D2FB98E8FQ26782613-9B2E2591-3BF8-4364-8F94-91D071203896Q26801108-66E5D81B-ED13-499F-9C28-7CC8837D3631Q26999684-F0360AA2-AF7D-4658-A995-3446BAC7D692Q27023576-4C05976D-7CC3-480B-9784-9159524A7E81Q27305351-6193CA78-FA5E-4444-A724-61EFAE75B4C7Q27330253-94D831D9-52C5-49B4-9BE6-15DDC8D36980Q28076805-00F066FE-47EC-42E3-A29E-F7177E099C94Q28085548-0481959C-E098-490E-A1DB-A1669080D72EQ28087523-2F92EFCA-5621-43F6-86A2-FBA3379B4140Q28390826-70D34A87-4360-4847-9462-3F1B85B90137Q28391909-CC7F643D-B3F9-44F6-934E-FF5267A48941Q30372977-FC4C809A-C4AB-400E-8C68-86E10BE8C1F2Q30378417-71B321B8-8BF8-447F-9A20-C2A4DD2D922EQ30529166-FF6AA2CF-2022-4087-BD29-AFD894EAEA71Q30597238-558B22EA-E1AA-43E1-B769-EDAAA6D23AA8Q30654061-F254B3ED-4338-4FF0-B1C0-461B5F46D573Q30949620-B5264654-0C15-45A7-AD12-F3C1AC60AA8FQ30966966-39F1C88A-372B-45FE-B3B9-76D9EC664548Q30978083-DCD77CCB-A6B9-40D7-95EE-9B40403C19D5Q33555247-A49B8877-8B0B-4CE0-8AA8-9F80CD7839BFQ33642033-E2A8BE84-FB1E-4070-B688-23AA4551A4E2Q33642824-7CF006CA-53D9-4EC1-BF1B-011029098585Q33658124-1F953913-3478-4414-BA4A-6BCB2F9AED90Q33660069-0B596C46-67E2-4C7F-8C92-50343ABFD93AQ33670486-D90541BC-689D-4D2E-831E-3358DDF7CB07Q33681837-648468C1-3A93-4B8F-9B69-B4BC1BE5D391Q33707489-43A7DB53-A3F3-403A-BAA2-029FD8629527Q33734466-B9D9AF5A-A911-4041-8B9E-0E95A8B094EAQ33750808-452066C1-420B-4B19-9B70-A386F8D7910FQ33845641-9B5FCC24-8516-4BB5-A267-DE28200560B4Q33849806-2CA93148-5B0E-47AB-BAB0-2429CFCBAF7AQ33868006-012825B8-308D-4859-A08F-6492E43927EAQ34025482-DD96A784-E09F-4F69-99A9-9D55FC9541C8Q34296534-650E3159-D9C4-4DAD-8511-2F5F1311E784Q34371518-86037810-8A62-4DBC-B085-011688B60787Q34396558-F9696B56-2764-4C41-9111-217070CB93D6Q34654576-86971D19-5710-4866-9F31-D00C5B751675Q34654714-BB467138-394D-44A4-9596-13034D922FF4Q34717298-416F30F4-489C-443F-870B-66D97B94E94F
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Heterogeneity in breast cancer.
@en
Heterogeneity in breast cancer.
@nl
type
label
Heterogeneity in breast cancer.
@en
Heterogeneity in breast cancer.
@nl
prefLabel
Heterogeneity in breast cancer.
@en
Heterogeneity in breast cancer.
@nl
P2860
P356
P1476
Heterogeneity in breast cancer.
@en
P2093
Kornelia Polyak
P2860
P304
P356
10.1172/JCI60534
P407
P577
2011-10-03T00:00:00Z